MedTrace Logo

SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem

NCT04497610 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-11-29

No results posted yet for this study

Summary

The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.

Conditions

  • COVID19

Interventions

DIAGNOSTIC_TEST

Breath sample

Patient will blow into a tube 5 times.

Sponsors & Collaborators

  • Instituto Costarricense de Investigaciones Clínicas ICIC

    lead OTHER

Principal Investigators

  • Guillermo Rodríguez Gómez, MD · Founder and Investigator

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • Costa Rica

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04497610 on ClinicalTrials.gov